Journey Medical Corporation (DERM) Q2 2024 Earnings
DERM·Reported August 12, 2024·After market close
Journey Medical Corporation reported Q2 2024 revenue of $14.9M, beat analyst consensus of $14.4M by $465.0K. Diluted EPS came in at $-0.17, missed the $-0.15 consensus by $0.02.
Revenue
$14.9Mbeat by $465.0K
Consensus: $14.4MDiluted EPS
$-0.17missed by $0.02
Consensus: $-0.15
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Journey Medical Corporation's Q2 2024 earnings report.
Journey Medical Corporation (DERM) reported Q2 2024 earnings on August 12, 2024 after market close.
Journey Medical Corporation reported revenue of $14.9M and diluted EPS of $-0.17 for Q2 2024.
Revenue beat the consensus estimate of $14.4M by $465.0K. EPS missed the consensus estimate of $-0.15 by $0.02.
You can read the 10-Q periodic report (0001410578-24-001326) directly on SEC EDGAR. The filing index links above go to sec.gov.